Applying genomics to diagnosis

Article Abstract:

A profile of some of the companies who are exploiting the technology behind delivering tests that use molecular diagnoses to understand a patient's disease and his response on an individual level is presented. Some of the companies profiled are Ambion Inc. , Epigenomics AG , Celera Genomics etc.

Germany, Forecasts, trends, outlooks, Management dynamics, Drugs, Management, Biotechnology industry, Biotechnology industries, Forecasts and trends, Market trend/market analysis, Celera Genomics Group, Company business management, Molecular genetics, Ambion Inc., Epigenomics AG, CRA

---

Business and strategy: development in diabetes

Article Abstract:

One of the technologies for monitoring glucose levels is a laser-based sensor being developed by SpectRx, Inc. in partnership with Abbott Laboratories. The monitor is worn on the top of the skin and it measures glucose levels in the interstitial fluid rather than blood.

Pharmaceutical preparations, Alliances, partnerships, Surgical and Medical Instrument Manufacturing, Surgical and medical instruments, Glucose Level Diagnostic Tests, Pharmaceutical industry, Diagnosis, Diabetes, Diabetes mellitus, Cooperative agreement for product development, Alliances and partnerships, ABT, Abbott Laboratories (Abbott Park, Illinois), Glucose monitors, SpectRx Inc.

---

Striking early against emerging infectious diseases : CBER pushes development of diagnostic platforms

Article Abstract:

The Center for Biologics Evaluation and Research (CBER) is trying to encourage companies to develop diagnostic technologies for infectious diseases before they surface instead of reacting to a health crisis.

Prevention, Communicable diseases, Diagnostic equipment (Medical), Medical testing products

Similar abstracts:

• Abstracts: The problematic fit of diagnosis and strategy for medical group stakeholders - including IDS/Ns
• Abstracts: The price of innovation: new estimates of drug development costs. Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research
• Abstracts: What goes around ... hospitals urged to assess their TB prevention plans. As hospital drug budgets soar, pharmacy's role is being rewritten
• Abstracts: The determinants and effects of health expenditure in developed countries. An econometric analysis of health care expenditure: a cross-section study of the OECD countries
• Abstracts: Joining forces: Maine hospitals find that cooperation brings results. 1992 receivables improved, but cash flow was weak

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.